Octean Pharma ApS: Financial statements 2024
CVR: 38023667
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Octean Pharma ApS (CVR 38023667) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 130,227 and a net result of DKK 102,485 compared with DKK 18,824 the year before. That is a decrease of 30.7% compared with the year before. Equity in the 2024 report amounted to DKK 222,148. The solvency ratio was 19.6%.
- Gross Profit
- DKK 130,227
- Profit/Loss
- DKK 102,485
- Equity
- DKK 222,148
- Total Assets
- DKK 1,135,695
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 130 t. | 102 t. | 222 t. | 0 |
| 2023 | - | 188 t. | 19 t. | 120 t. | 1 |
| 2022 | - | 571 t. | 11 t. | 101 t. | 1 |
| 2021 | - | 1.2 mio. | 43 t. | 90 t. | 1 |
| 2020 | 1.3 mio. | 793 t. | 11 t. | 47 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Octean Pharma ApS has published its annual report for 2023. Gross profit came to DKK 187,912, and the net result was DKK 18,824.
About Octean Pharma ApS
Octean Pharma ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Detailhandel med andre fødevarer. The management consists of Lotte Johannesson. The company is owned by Halobid Aktiebolag. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,152 and a net result of DKK -15,398 compared with DKK 102,485 the year before. Equity in the 2025 report amounted to DKK 206,750.